Ensovi leverages ginkgo enzyme services to optimize cell-free carbon fixation process for biomanufacturing

Boston , sept. 28, 2023 /prnewswire/ -- ensovi inc., which has invented an efficient, cell-free biomanufacturing platform that transforms waste co2 to organic chemicals, today announced a new partnership with ginkgo bioworks (nyse: dna), which is building the leading platform for cell programming and biosecurity.
DNA Ratings Summary
DNA Quant Ranking